Article

Renin-angiotensin system blockers and susceptibility to COVID-19: a multinational open science cohort study

2020-06-12

Abstract excerpt

<h4>Introduction</h4> Angiotensin converting enzyme inhibitors (ACEs) and angiotensin receptor blockers (ARBs) could influence infection risk of coronavirus disease (COVID-19). Observational studies to date lack pre-specification, transparency, rigorous ascertainment adjustment and international generalizability, with contradictory results. <h4>Methods</h4> Using electronic health records from Spain (SIDIAP) and t...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 6e13cf72-55c3-5b5e-ad17-a390a40c2587
DOI: 10.1101/2020.06.11.20125849

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Renin-angiotensin system blockers and susceptibility to COVID-19: a multinational open science cohort studyDOI 10.1101/2020.06.11.20125849Read

Severity of COVID-19 Infection in ACEI/ARB Users in Two Saudi Public Specialty Hospitals: Retrospective Cohort StudySemantic proximity Read

Severity of COVID-19 Infection in ACEI/ARB Users in Two Saudi Public Specialty Hospitals; Retrospective Cohort StudySemantic proximity Read

Mortality and Severity in COVID-19 Patients on ACEIs & ARBs - A Meta-Regression AnalysisSemantic proximity Read

ARB/ACEI use and severe COVID-19: a nationwide case-control studySemantic proximity Read

Association of Renin-Angiotensin-Aldosterone System Inhibition with Risk of COVID-19, Inflammation Level, Severity and Death in Patients With COVID-19: A Rapid Systematic Review and Meta-AnalysisSemantic proximity Read

A Low Aldosterone/Renin Ratio and High Soluble ACE2 Associate with COVID-19 SeveritySemantic proximity Read

Impact of Renin-Angiotensin-Aldosterone System Inhibition on Mortality in Critically Ill COVID-19 Patients with Pre-Existing Hypertension: A Prospective Cohort StudySemantic proximity Read

Angiotensin-converting enzyme inhibitors (ACEI) or Angiotensin receptor blockers (ARBs) may be safe for COVID-19 patientsSemantic proximity Read

Effect of in-hospital treatment with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on mortality and complications in patients hospitalized for COVID-19: a large Spanish cohort studySemantic proximity Read

ACE inhibitors, AT1 receptor blockers and COVID-19: clinical epidemiology evidences for a continuation of treatments. The ACER-COVID studySemantic proximity Read

Cardiovascular Therapy and Mortality in Hospitalized Patients With COVID-19: A Cohort StudySemantic proximity Read

Hypertension in patients hospitalized with COVID-19 in Wuhan, China: A single-center retrospective observational studySemantic proximity Read